Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research

NCT02513355 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: Endostar
DRUG: Changchun marina
DRUG: cisplatin
DRUG: Taxol
DRUG: parapl

Sponsor

Nanjing NingQi Medicine Science and Technology Co., Ltd.